Skip to main content

Table 2 Selected single-nucleotide polymorphisms in relation to vitamin D level and breast cancer

From: SNPs related to vitamin D and breast cancer risk: a case-control study

SNP (GWAS SNP)

Risk of low vitamin D

Risk of breast cancer

Allele

Frequency of low/high vitamin Da (n = 1343)

Crude OR of low vitamin D (95% CI)

Adjusted ORb of low vitamin D (95% CI)

Cases/control subjects (n = 4058)

Crude OR (95% CI)

Adjusted ORb (95% CI)

rs12239582 (rs12144344)

 CC

224/188

1.00

1.00

290/986

1.00

1.00

 CA

344/336

0.86 (0.67–1.10)

0.87 (0.67–1.12)

412/1604

0.87 (0.74–1.04)

0.82 (0.68–0.99)

 AA

116/135

0.72 (0.53–0.99)

0.72 (0.52–1.00)

163/600

0.92 (0.74–1.15)

0.93 (0.73–1.17)

 Missing

0/3

rs705117

 CC

504/486

1.00

1.00

657/2376

1.00

1.00

 CT

164/168

0.94 (0.73–1.21)

0.94 (0.73–1.22)

194/762

0.92 (0.77–1.10)

0.86 (0.71–1.05)

 TT

16/5

3.06 (1.11–8.44)

3.38 (1.20–9.49)

14/55

0.92 (0.51–1.67)

0.94 (0.49–1.81)

rs7041

 AA

213/270

1.00

1.00

332/1149

1.00

1.00

 AC

341/308

1.40 (1.11–1.78)

1.39 (1.09–1.77)

397/1521

0.90 (0.77–1.07)

0.88 (0.74–1.05)

 CC

130/81

2.03 (1.46–2.83)

2.12 (1.51–2.99)

136/522

0.90 (0.72–1.13)

0.89 (0.70–1.13)

 Missing

0/1

rs2282679 (rs17467825)

 GG

342/397

1.00

1.00

480/1734

1.00

1.00

 GT

278/230

1.40 (1.12–1.76)

1.42 (1.13–1.80)

326/1222

0.96 (0.82–1.13)

0.98 (0.83–1.16)

 TT

62/29

2.45 (1.56–3.95)

2.51 (1.56–4.05)

57/229

0.90 (0.66–1.22)

0.91 (0.66–1.27)

 Missing

2/3

2/8

rs10485165

 TT

515/501

1.00

1.00

650/2385

1.00

1.00

 TC

153/144

1.04 (0.80–1.35)

1.03 (0.79–1.34)

194/735

0.97 (0.81–1.16)

0.99 (0.82–1.20)

 CC

16/14

1.10 (0.53–2.29)

1.04 (0.49–2.21)

21/73

1.06 (0.65–1.73)

1.00 (0.60–1.74)

rs198300 (rs156299)

 GG

218/229

1.00

1.00

295/1134

1.00

1.00

 GA

344/319

1.13 (0.89–1.44)

1.08 (0.84–1.38)

430/1513

1.09 (0.92–1.29)

1.10 (0.91–1.30)

 AA

122/111

1.16 (0.84–1.59)

1.09 (0.79–1.52)

140/545

0.99 (0.79–1.24)

0.96 (0.75–1.22)

 Missing

0/1

rs4751058

 AA

496/460

1.00

1.00

614/2286

1.00

1.00

 AG

174/183

0.88 (0.69–1.13)

0.88 (0.68–1.13)

234/828

1.05 (0.89–1.25)

1.05 (0.88–1.27)

 GG

14/16

0.81 (0.39–1.68)

0.77 (0.36–1.63)

17/79

0.80 (0.47–1.36)

0.66 (0.38–1.17)

rs12295888 (rs12287212)

 CC

270/296

1.00

1.00

367/1384

1.00

1.00

 CT

321/302

1.16 (0.93–1.46)

1.22 (0.96–1.54)

402/1435

1.06 (0.90–1.24)

1.05 (0.88–1.24)

 TT

93/61

1.67 (1.16–2.40)

1.80 (1.24–2.63)

96/373

0.97 (0.75–1.25)

0.93 (0.71–1.23)

 Missing

0/1

rs1007392

 GG

231/267

1.00

1.00

325/1184

1.00

1.00

 GA

337/310

1.26 (0.99–1.59)

1.31 (1.03–1.67)

417/1543

0.99 (0.84–1.16)

0.99 (0.83–1.18)

 AA

115/82

1.62 (1.16–2.26)

1.78 (1.26–2.52)

123/462

0.97 (0.77–1.23)

0.91 (0.71–1.17)

 Missing

1/0

0/4

rs2060793 (rs10741657)

 AA

246/194

1.00

1.00

283/1040

1.00

1.00

 AG

328/323

0.80 (0.63–1.02)

0.78 (0.61–1.00)

418/1544

1.00 (0.84–1.18)

1.10 (0.92–1.33)

 GG

110/142

0.61 (0.45–0.84)

0.58 (0.42–0.81)

164/606

1.00 (0.80–1.24)

1.04 (0.82–1.32)

 Missing

0/3

rs7944926 (rs12785878)

 AA

297/343

1.00

1.00

423/1436

1.00

1.00

 AG

299/272

1.27 (1.01–1.59)

1.30 (1.03–1.64)

366/1400

0.89 (0.76–1.04)

0.91 (0.77–1.08)

 GG

88/44

2.31 (1.56–3.43)

2.39 (1.59–3.59)

76/356

0.73 (0.55–0.95)

0.77 (0.57–1.02)

 Missing

0/1

rs3829251

 AA

402/435

1.00

1.00

545/1954

1.00

1.00

 AG

242/210

1.25 (0.99–1.57)

1.30 (1.02–1.64)

287/1079

0.95 (0.81–1.12)

0.99 (0.83–1.18)

 GG

40/14

3.09 (1.65–5.77)

3.26 (1.72–6.17)

33/160

0.74(0.50–1.09)

0.77 (0.51–1.16)

rs2302190

 CC

451/466

1.00

1.00

566/2122

1.00

1.00

 CT

211/176

1.24 (0.98–1.57)

1.24 (0.97–1.58)

268/955

1.05(0.89–1.24)

1.09 (0.91–1.30)

 TT

20/13

1.59 (0.78–3.23)

1.45 (0.69–3.02)

28/109

0.96 (0.63–1.47)

0.99 (0.62–1.58)

 Missing

2/4

3/7

  1. GWAS Genome-wide association study, SNP Single-nucleotide polymorphism
  2. aLow vs high vitamin D grouped by calendar month
  3. bAdjusted for age at baseline, year of inclusion, level of education, type of occupation, age at menarche, age at first childbirth, exposure to oral contraceptives, exposure to hormone replacement therapy, height, body mass index, alcohol consumption and smoking